5-Hydroxylysine is a post-translationally modified amino acid derived from lysine, first identified in 1921. It is primarily recognized as a pharmaceutical intermediate used in the manufacturing of specialized compounds.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1190-94-9
3-(2-{Bis[(²H₃)methyl]amino}-2-oxoethyl)-2-(4-methylphenyl)imidazo[1,2-a]pyridine-6-carboxylic acid
pharmaceutical intermediate
Glimepiride sulfonamide
pharmaceutical intermediate
(S)-1-N-Boc-2-(aminomethyl)pyrrolidine
pharmaceutical intermediate
(S)-2-(Aminomethyl)-1-Cbz-pyrrolidine
pharmaceutical intermediate
Threo-5-hydroxy-L-lysine
pharmaceutical intermediate
(2S,5R)-2,6-diamino-5-hydroxyhexanoic acid
YSMODUONRAFBET-UHNVWZDZSA-N
C(C[C@@H](C(=O)O)N)[C@H](CN)O